Skip to main content

Top 10: Most-read COVID-19 articles in ClinicalKey from last year

As the pandemic continued through 2021, so too did the volume and breadth of COVID-19 research and rapid publication of scientific papers. Vaccines and prevention, treatments and complications associated with the disease are among the prevalent themes in these popular COVID-19 ClinicalKey articles published in 2021:

  1. Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19. Santin AD, Scheim DE, McCullough PA, et al. New Microbes and New Infections. 2021 Aug 3;43:100924.
  2. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. Banerji A, Wickner PG, Saff R, et al.
    The Journal of Allergy and Clinical Immunology: In Practice. 2021 Apr;9(4):1423-1437.
  3. Oxford–AstraZeneca COVID-19 vaccine efficacy. Knoll MD; Wonodi, C. The Lancet. 2021 Jan 9; 397(10269):72-74.
  4. Impact of COVID-19 Pandemic on College Student Mental Health and Wellness. Copeland WE, McGinnis E, Bai Y, et al. Journal of the American Academy of Child & Adolescent Psychiatry. 2021 Jan;60(1):134-141.
  5. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Menni C, Klaser K, May A, et al. The Lancet Infectious diseases. 2021 Jul;21(7):939-949.
  6. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Ahmed S, Karim MM, Ross AG, et al. International Journal of Infectious Diseases. 2021 Feb;103:214-216.
  7. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Huang C, Huang L, Wang Y, et al.  The Lancet. 2021 Jan 16;397(10270):220-232.
  8. Face masks to prevent transmission of COVID-19: A systematic review and meta-analysis. Li Y, Liang M, Gao L, et al. American Journal of Infection Control. 2021 Jul;49(7):900-906.
  9. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. McMahon DE, Amerson E, Rosenbach M, et al. Journal of the American Academy of Dermatology. 2021 Jul;85(1):46-55.
  10. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. RECOVERY Collaborative Group. The Lancet. 2021 May 1;397(10285):1637-1645.

ClinicalKey user tip: stay current on COVID-19 and other clinical topics by activating your ClinicalKey account and setting up journal issue alerts. Learn more here.

About ClinicalKey

ClinicalKey provides access to evidence across 30+ specialties via full-text books and journals, point-of-care summaries, drug information, videos, practice guidelines, and customizable patient handouts.

Access to ClinicalKey, a tool valued at US$1,200 per year, is included with a CMA membership.

Do you have a question on COVID-19 or another clinical topic? Contact the Ask a Librarian team to request a literature search.

 

About the author(s)

CMA Joule’s medical librarians are the professionals behind “Ask a Librarian”, a service for all CMA members looking for clinical search expertise. This experienced team of librarians can support you by searching on your behalf, teaching you effective search strategies or training you to use our clinical resources.